IHS Chemical Week

EnviroTech :: Innovation

Avecia Wins Pharma Innovation Award for Expression Technology

10:29 AM MDT | October 30, 2007 | Michelle Bryner with Alex Scott in Milan

Avecia Biologics (Tees Valley, U.K.) has won CPhI’s Innovation award for its pAVEway biopharma E.coli expression technology that can be used to manufacture biopharmaceuticals. CPhI, which established the award program to recognize the pharma industry’s advances in science and technology, presented this year’s awards at its pharmaceutical manufacturing expo, held last month in Milan (CW, Oct. 10/17, p. 34). Expressive show: Johannes de Vries of DSM; Jon Williams of Avecia; and Karen Holt-Tiffin of Dowpharma accept awards. Unlike many of its...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa